Search Results
Imugene begins VAXINIA trial for bile tract cancer
Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success
Imugene Investor Webinar: MAST Study Update
Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US
Imugene (ASX:IMU) | Webinar with Leslie Chong | 07/11/24
